Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-113-5 | CAS number: 103-45-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Study period:
- 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Not following a guideline, no evidence of GLP. This study was conducted with the aim of evaluating the effectiveness of the protocol
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Benzyl acetate was tested in a mouse bone marrow micronucleus test that employed three daily exposures by intraperitoneal injection. Bone marrow samples were obtained 24 hr following the final exposure. This study was conducted as part of an effort to assess the ability of the micronucleus test to discriminate between rodent carcinogens and noncarcinogens and to determine its potential role, in combination with other short term tests, in identifying genotoxic chemicals that present a carcinogenic hazard.
- GLP compliance:
- not specified
- Type of assay:
- micronucleus assay
Test animals
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: National Toxicology Program production facility
- Age at study initiation: between 9 and 14 weeks
- Weight at study initiation: 25 - 33 g
Note: reference within report to further data on animal husbandry to be found in Tice et al 1991a
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: water insoluble substance
- Concentration of test material in vehicle: 0, 312, 625, 1250 mg/kg
- Amount of vehicle (if gavage or dermal): 0.4 ml - Details on exposure:
- Benzyl acetate was prepared in corn oil and suspended using Tek-Mar Tissumizer. The test substance was administered within 30 minutes of preparation.
- Duration of treatment / exposure:
- Dose determination study: IP injection on three consecutive days
MN Induction: IP injection on three consecutive days - Frequency of treatment:
- Dose determination study: Daily
MN Induction: Daily - Post exposure period:
- Dose determination study: 48 hours after the third treatment
MN Induction: 24 hours after the third treatment
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
312 mg/kg bw/day
Basis:
other: Injected intraperitoneal
- Remarks:
- Doses / Concentrations:
625 mg/kg bw/day
Basis:
other: Injected intraperitoneal
- Remarks:
- Doses / Concentrations:
1250 mg/kg bw/day
Basis:
other: Injected intraperitoneal
- No. of animals per sex per dose:
- Dose determination study: 5 mice
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- 7,12-dimethylbenzanthracene
- Route of administration: intraperitoneal injection
- Doses / concentrations: weakly active dose
Examinations
- Tissues and cell types examined:
- Dose determination study: Bone marrow and peripheral blood smears (two slides/tissue/mouse)
- Details of tissue and slide preparation:
- Dose determination study:
CRITERIA FOR DOSE SELECTION: The selection of the maximum dose to be tested was based on either mortality, administration characteristics, depression in percentage of bone marrow, or arbitrary maximum dose of 2000 mg/kg/day.
TREATMENT AND SAMPLING TIMES: Groups of 5 mice were administered the test chemical by intraperitoneal injection on three consecutive days. Animals were monitored twice daily and 48 hours after the third treatement the survivng mice were euthanized by CO2 asphyxiation. Bone marrow and peripheral blood smears (two slides/tissue/mouse) by a direct technique.
DETAILS OF SLIDE PREPARATION: Air-dried smears were fixed using absolute methanol and stained with acridine orange.
METHOD OF ANALYSIS:Bone marrow smears from each animal were evaluated at 1000x magnification using epi-illuminated Fluorescence microscopy (450-490 nm excitation, 520 nJ;ll emission) for determination of the percentage of PCE among 200 erythrocytes.
MN Induction:
CRITERIA FOR DOSE SELECTION: Based on the dose selection study.
TREATMENT AND SAMPLING TIMES: Groups of 5-7 mice were administered the test chemical by intraperitoneal inhection on three consecutive days. 24 hours after the third treatement mice were euthanized by CO2 asphyxiation. Bone marrow and peripheral blood smears (two slides/tissue/mouse) were prepared.
DETAILS OF SLIDE PREPARATION: Bone marrow smears (two slides mouse) were prepared, fixed in absolute methanol, and stained with acridine orange.
METHOD OF ANALYSIS:For each animal, slides were evaluated at I,000 X magnification for the number of MN-PCE among 2,000 PCE and for the percentage of PCE among 200 erythrocytes. - Evaluation criteria:
- The test conclusions are based on the statistical analysis of trend and of pairwise comparisons of the solvent control with individual doses and the absolute increases in MN-PCE frequency.
- Statistics:
- The data were analyzed using the Micronucleus Assay Data Management and Statistical software package (version 1.4), which was designed specifically for in vivo micronucleus data. The level of significance was set at an alpha level of 0.05. To determine whether a specific treatment resulted in a significant increase in MN-PCE, the number of MN-PCE were pooled within each dose group and analyzed by a one-tailed trend test. In the software package used, the trend test incorporates a variance innation factor to account for excess animal variability. In the event that the increase in the dose response curve is nonmonotonic, the software program allows for the data to be analyzed for a significant positive trend after data at the highest dose only has been excluded. However, in this event, the alpha level is adjusted to 0.01 to protect against false positives. The %PCE data were analyzed by an analysis of variance (ANOVA) test based on pooled data. Pairwise comparisons between each group and the concurrent solvent control group was by an unadjusted one-tailed Pearson chisquared test which incorporated the calculated variance innation factor for the study.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- not specified
- Vehicle controls validity:
- valid
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- No further data
Any other information on results incl. tables
Dose (mg/kg) |
MN-PEC/1000 (no of animals) |
Pairwise |
Survival |
%PCE |
0 |
3.00+0.69 |
|
5/5 |
69.9 |
312 |
2.90+0.60 |
0.5519 |
5/5 |
65.8 |
625 |
3.20+0.60 |
0.3396 |
5/5 |
64.3 |
1250 |
1.80+0.46 |
0.9586 |
6/6 |
60.7 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
The initial test was negative to 1,250 mg/kg and was not repeated. According to Directive 67/548/EEC, no classification is warranted. According to Regulation (EC) No. 1272/2008, no classification is warranted. - Executive summary:
Benzyl acetate was tested in a mouse bone marrow micronucleus test that employed three daily exposures by intraperitoneal injection. Bone marrow samples were obtained 24 hr following the final exposure. This study was conducted as part of an effort to assess the ability of the micronucleus test to discriminate between rodent carcinogens and noncarcinogens and to determine its potential role, in combination with other short term tests, in identifying genotoxic chemicals that present a carcinogenic hazard. The initial test was negative to 1,250 mg/kg and was not repeated. According to Directive 67/548/EEC, no classification is warranted. According to Regulation (EC) No. 1272/2008, no classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.